ACE and Cushing syndrome due to macronodular adrenal hyperplasia: While the design of our study does not allow to draw conclusions regarding the optimal antihypertensive treatment for patients with Cushing’s syndrome, the reduction in ACE activity does not support the use of an ACE inhibitor as first-line treatment as suggested by some authors (5, 31).